Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Promyelocytic Leukemia (APL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00002588
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia

Who this might be right for
Leukemia
Case Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT05881265
What this trial is testing

Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia

Who this might be right for
APL
Shanghai Jiao Tong University School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT00313586
What this trial is testing

Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+12 more
National Cancer Institute (NCI) 197
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Testing effectiveness (Phase 2)UnknownNCT01064570
What this trial is testing

AIDA 2000 Guidelines

Who this might be right for
Acute Promyelocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 600
Testing effectiveness (Phase 2)WithdrawnNCT00670150
What this trial is testing

New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia
University of Southern California
Testing effectiveness (Phase 2)Study completedNCT01253070
What this trial is testing

Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1+3 more
National Cancer Institute (NCI) 54
Not applicableApproved For MarketingNCT01869803
What this trial is testing

Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Ended earlyNCT01018069
What this trial is testing

AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen

Who this might be right for
Leukemia
Aegera Therapeutics 60
Large-scale testing (Phase 3)UnknownNCT00378365
What this trial is testing

Acute Promyelocytic Leukemia 2006 (APL)

Who this might be right for
Leukemia, Promyelocytic, Acute
Assistance Publique - Hôpitaux de Paris 800
Testing effectiveness (Phase 2)Study completedNCT00016159
What this trial is testing

Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 35
Not applicableStudy completedNCT00899015
What this trial is testing

Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J

Who this might be right for
LeukemiaLymphoma
National Institutes of Health Clinical Center (CC) 23
Not applicableStudy completedNCT01232855
What this trial is testing

Biomarkers in Tissue Samples From Patients With Acute Promyelocytic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 10
Large-scale testing (Phase 3)UnknownNCT00002658
What this trial is testing

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
LeukemiaNeutropenia
Medical Research Council 2,000
Early research (Phase 1)Study completedNCT00077467
What this trial is testing

Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 36
Not applicableEnded earlyNCT02309333
What this trial is testing

Impact of a Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL) by Maintaining a Database

Who this might be right for
Leukemia, Promyelocytic, Acute
Emory University 117
Testing effectiveness (Phase 2)Ended earlyNCT00184054
What this trial is testing

Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
University of Southern California 11
Not applicableLooking for participantsNCT04897490
What this trial is testing

RWE of 1st Line Treatment With ATO/ATRA for Adult APL

Who this might be right for
Promyelocytic Leukemia, Adult Acute
Grupo Argentino de Tratamiento de la Leucemia Aguda 50
Early research (Phase 1)Study completedNCT00098826
What this trial is testing

SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+24 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT03989713
What this trial is testing

Quizartinib and High-dose Ara-C Plus Mitoxantrone in Relapsed/Refractory AML With FLT3-ITD

Who this might be right for
AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
Prof. Dr. Richard F Schlenk 11
Next Page